Chloroquine for Glioblastoma.
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT
- Status
- TERMINATED
- Phase
- NA
A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Glioblastoma Radiotherapy Using IMRT or Proton Beams
- Status
- RECRUITING
- Phase
- NA
Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Monocyte Antigen Carrier Cells for Newly Diagnosed GBM
- Status
- WITHDRAWN
- Phase
- PHASE1
SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
- Status
- COMPLETED
- Phase
- NA
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma
- Status
- COMPLETED
- Phase
- NA
TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study
- Status
- UNKNOWN
- Phase
- N/A
Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
- Status
- RECRUITING
- Phase
- N/A
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
- Status
- RECRUITING
- Phase
- NA
A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma
- Status
- SUSPENDED
- Phase
- N/A
AB154 Combined With AB122 for Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1